M&A Deal Summary |
|
|---|---|
| Date | 2017-12-07 |
| Target | Entellus Medical |
| Sector | Medical Products |
| Buyer(s) | Stryker |
| Sellers(s) | EW Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 662M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1941 |
| Sector | Medical Products |
| Employees | 52,000 |
| Revenue | 22.6B USD (2024) |
Stryker is a medical technology company that offers innovative products and services in MedSurg, Neurotechnology and Orthopaedics including implants, surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, neurosurgical, neurovascular and spinal devices. Stryker was founded in 1941 and is based in Portage, Michigan.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 49 |
| Sector: Medical Products M&A | 22 of 36 |
| Type: Add-on Acquisition M&A Deals | 26 of 43 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 22 of 34 |
| Year: 2017 M&A | 4 of 4 |
| Size (of disclosed) | 10 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-10-24 |
Vexim SA
Balma, France Vexim SA is a medical device company, designs and markets minimally invasive solutions for the treatment of traumatic spinal pathologies. Company specializes in the development and sale of vertebral compression fracture (VCF) solutions. The company’s flagship product is the SpineJack® system, a mechanical expandable VCF implant for fracture reduction and stabilization. The VEXIM portfolio is highly complementary to the Interventional Spine (IVS) business of Stryker’s Instruments division whose key products include an extensive and innovative portfolio for vertebral augmentation, vertebroplasty and radiofrequency ablation procedures, along with a diagnostic tool and decompression treatment advances for contained disc herniations. |
Buy | €162M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-25 |
SafeAir AG
Root Längenbold, Switzerland SafeAir AG is a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions. The company's smoke evacuation products help reduce staff and patient exposure to hazards associated with surgical smoke. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 45 of 53 |
| Sector: Medical Products M&A | 21 of 24 |
| Type: Add-on Acquisition M&A Deals | 29 of 34 |
| State: Minnesota M&A | 2 of 2 |
| Country: United States M&A | 40 of 46 |
| Year: 2017 M&A | 5 of 5 |
| Size (of disclosed) | 3 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-22 |
Grupo Farmaceutico Biotoscana
Montevideo, Uruguay Grupo Farmaceutico Biotoscana is a biopharmaceutical group that focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Grupo Farmaceutico Biotoscana was formed in 1994 and is based in Montevideo, Uruguay. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-02-20 |
Cognate BioServices
Memphis, Tennessee, United States Cognate BioServices, Inc. is a fully-integrated contract bioservices organization that provides a systematic level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products. Cognate BioServices was founded in 2002 and is based in Memphis, Tennessee. |
Buy | - |
